Increased sensitivity to restraint stress and novelty-induced emotionality following long-term, high dose cannabinoid exposure.
- Authors
- Hill, Matthew N; Gorzalka, Boris B
- Year
- 2006
- Journal
- Psychoneuroendocrinology
- PMID
- 16442741
- DOI
- 10.1016/j.psyneuen.2005.11.010
Cannabinoids have long been known to affect anxiety, emotionality and stress responsivity; however, the direction of this effect has been controversial. This research aimed to compare the effects of chronic administration of both a very low dose (5 microg/kg) and a very high dose (100 microg/kg) of the potent cannabinoid CB(1) receptor agonist HU-210 on emotionality and stress responsivity. Twelve day administration of the high dose of HU-210 increased anxiety-like behavior as indicated by a significant reduction in time spent in the central quadrant and an increase in fecal boli in the open field test. However, neither dose of HU-210 elicited any significant behavioral effect in the elevated plus maze. Stress responsivity appeared to be sensitized in animals that had received high dose HU-210 treatment, as 30 min of restraint resulted in significantly higher plasma corticosterone levels in these subjects than in stressed controls or those receiving the low dose treatment. Furthermore, restraint stress elicited a non-significant increase in c-fos induction in the central amygdala, which was significantly potentiated following high-dose treatment with HU-210. This interaction was not seen in the basolateral amygdala. Together, these findings suggest that chronic high dose, but not low dose, cannabinoid administration may result in increased emotionality and sensitization of the stress axis.
No figures extracted from this document.
No chunks β full text not yet ingested.
No entities extracted from this document yet.
No uploaded files.
No citations found.
In this knowledge base
External
| Title | Authors | Journal | Year | Link |
|---|---|---|---|---|
| Memory impairment and chronic high-dose Ξ9-THC/cannabis exposure: a narrative review of molecular mechanisms underlying neurotoxic effects. | Mashayekhi-Sardoo H et al. | β | 2026 | β |
| Cannabidiol improves Nile tilapia cichlid fish welfare. | Camargo-Dos-Santos B et al. | β | 2022 | β |
| Targeting the cannabinoid system to counteract the deleterious effects of stress in Alzheimer's disease. | Shade RD et al. | β | 2022 | β |
| Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior. | Farinha-Ferreira M et al. | β | 2022 | β |
| A review of the effects of acute and chronic cannabinoid exposure on the stress response. | Glodosky NC et al. | β | 2021 | β |
| Unexpected short- and long-term effects of chronic adolescent HU-210 exposure on emotional behavior | Farinha-Ferreira M et al. | β | 2021 | β |
| Endocannabinoid Signaling in the Central Amygdala and Bed Nucleus of the Stria Terminalis: Implications for the Pathophysiology and Treatment of Alcohol Use Disorder. | Bedse G et al. | β | 2019 | β |
| Brain endocannabinoid signaling exhibits remarkable complexity. | Gorzkiewicz A et al. | β | 2018 | β |
| Viral-mediated overexpression of the Myelin Transcription Factor 1 (MyT1) in the dentate gyrus attenuates anxiety- and ethanol-related behaviors in rats. | Bahi A et al. | β | 2017 | β |
| Substance use modulates stress reactivity: Behavioral and physiological outcomes. | Fosnocht AQ et al. | β | 2016 | β |
| Monoacylglycerol lipase (MGLL) polymorphism rs604300 interacts with childhood adversity to predict cannabis dependence symptoms and amygdala habituation: Evidence from an endocannabinoid system-level analysis. | Carey CE et al. | β | 2015 | β |
| Chronic THC during adolescence increases the vulnerability to stress-induced relapse to heroin seeking in adult rats. | Stopponi S et al. | β | 2014 | β |
| Endocannabinoid signaling in the etiology and treatment of major depressive illness. | Hillard CJ et al. | β | 2014 | β |
| Sex, drugs, and adult neurogenesis: sex-dependent effects of escalating adolescent cannabinoid exposure on adult hippocampal neurogenesis, stress reactivity, and amphetamine sensitization. | Lee TT et al. | β | 2014 | β |
| Synthetic cannabinoids: epidemiology, pharmacodynamics, and clinical implications. | Castaneto MS et al. | β | 2014 | β |
| Behavioral responses to acute and sub-chronic administration of the synthetic cannabinoid JWH-018 in adult mice prenatally exposed to corticosterone. | MacrΓ¬ S et al. | β | 2013 | β |
| Cannabidiol blocks long-lasting behavioral consequences of predator threat stress: possible involvement of 5HT1A receptors. | Campos AC et al. | β | 2012 | β |
| Neuroanatomical substrates involved in cannabinoid modulation of defensive responses. | Moreira FA et al. | β | 2012 | β |
| Sex-dependent effects of maternal deprivation and adolescent cannabinoid treatment on adult rat behaviour. | Llorente-Berzal A et al. | β | 2011 | β |
| Facilitation of endocannabinoid effects in the ventral hippocampus modulates anxiety-like behaviors depending on previous stress experience. | Campos AC et al. | β | 2010 | β |
| Preservation of striatal cannabinoid CB1 receptor function correlates with the antianxiety effects of fatty acid amide hydrolase inhibition. | Rossi S et al. | β | 2010 | β |
| Monoaminergic neurotransmission contributes to cannabinoid-induced activation of the hypothalamic-pituitary-adrenal axis. | McLaughlin RJ et al. | β | 2009 | β |
| Protracted cannabinoid administration elicits antidepressant behavioral responses in rats: role of gender and noradrenergic transmission. | Morrish AC et al. | β | 2009 | β |
| Suppression of amygdalar endocannabinoid signaling by stress contributes to activation of the hypothalamic-pituitary-adrenal axis. | Hill MN et al. | β | 2009 | β |
| Assessment of estradiol influence on spatial tasks and hippocampal CA1 spines: evidence that the duration of hormone deprivation after ovariectomy compromises 17beta-estradiol effectiveness in altering CA1 spines. | McLaughlin KJ et al. | β | 2008 | β |
| Chronic psychoemotional stress impairs cannabinoid-receptor-mediated control of GABA transmission in the striatum. | Rossi S et al. | β | 2008 | β |
| Subchronic cannabinoid agonist (WIN 55,212-2) treatment during cocaine abstinence alters subsequent cocaine seeking behavior. | GonzΓ‘lez-Cuevas G et al. | β | 2007 | β |